aRigen Pharmaceuticals, Inc. ' Product Pipeline Review ' 2012

Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!

aRigen Pharmaceuticals, Inc. ' Product Pipeline Review ' 2012
Published on August 2012

Report Summary


Summary

Global Markets Direct's pharmaceuticals report, 'aRigen Pharmaceuticals, Inc. - Product Pipeline Review - 2012' provides data on the
aRigen Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline,
complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, aRigen Pharmaceuticals,
Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from aRigen Pharmaceuticals, Inc. and
industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- aRigen Pharmaceuticals, Inc. - Brief aRigen Pharmaceuticals, Inc. overview including business description, key information and
facts, and its locations and subsidiaries.
- Review of current pipeline of aRigen Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities,
across the globe.
- Product profiles for late stage and clinical stage products of aRigen Pharmaceuticals, Inc. with complete description of the product's
developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the aRigen Pharmaceuticals, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate aRigen Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of aRigen Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the aRigen Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic
initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with aRigen Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of aRigen Pharmaceuticals, Inc. and identify potential opportunities in those areas.

aRigen Pharmaceuticals, Inc. ' Product Pipeline Review ' 2012 (From Slideshare) Page 1/6


Table of Content

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
aRigen Pharmaceuticals, Inc. Snapshot 5
aRigen Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
aRigen Pharmaceuticals, Inc. ' Research and Development Overview 6
Key Therapeutic Areas 6
aRigen Pharmaceuticals, Inc. ' Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products ' Monotherapy 10
aRigen Pharmaceuticals, Inc. ' Pipeline Products Glance 11
aRigen Pharmaceuticals, Inc. ' Late Stage Pipeline 11
Phase III Products/Combination Treatment Modalities 11
aRigen Pharmaceuticals, Inc. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
aRigen Pharmaceuticals, Inc. ' Early Stage Pipeline Products 14
Pre-Clinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
aRigen Pharmaceuticals, Inc. ' Drug Profiles 16
ARA-01 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ARB-CF0223 17
R&D Progress 17
ARH-1029 18
R&D Progress 18
ARM-AK105 19
R&D Progress 19
ARV-SR0121 20
R&D Progress 20
ARYS-01 21



R&D Progress 21
WAP-8294A2 22
R&D Progress 22
aRigen Pharmaceuticals, Inc. ' Pipeline Products by Route of Administration 24
aRigen Pharmaceuticals, Inc. ' Pipeline Products By Mechanism of Action 25
aRigen Pharmaceuticals, Inc. ' Recent Pipeline Updates 26
aRigen Pharmaceuticals, Inc. - Dormant Projects 27
aRigen Pharmaceuticals, Inc. ' Locations And Subsidiaries 28
Head Office 28
aRigen Pharmaceuticals, Inc., Recent Developments 29
aRigen Pharmaceuticals, Inc.- Press Release 29
Aug 17, 2009: aRigen Pharmaceuticals Receives Two-Thirds Of R&D Costs For WAP-8294A2 From NEDO 29
Apr 30, 2009: Axentis Pharma AG Announces Of Granting Orphan Drug Designation For Innovative Treatment Against Lung
Infections 29
Financial Deals Landscape 31
aRigen Pharmaceuticals, Inc., Deals Summary 31
aRigen Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 32
Licensing Agreements 32
Green Cross Enters Into Licensing Agreement With aRigen 32
Centaur Pharma Enters Into Licensing Agreement With aRigen Pharma 34
aRigen Pharma Enters Into Licensing Agreement With CJ CheilJedang For ARH-1029 35
aRigen Pharma Enters Into Licensing Agreement With Taiho Pharma 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 38
Disclaimer 38

List of Tables

aRigen Pharmaceuticals, Inc., Key Information 5
aRigen Pharmaceuticals, Inc., Key Facts 5
aRigen Pharmaceuticals, Inc. ' Pipeline by Indication, 2012 8
aRigen Pharmaceuticals, Inc. ' Pipeline by Stage of Development, 2012 9
aRigen Pharmaceuticals, Inc. ' Monotherapy Products in Pipeline, 2012 10
aRigen Pharmaceuticals, Inc. ' Phase III, 2012 11
aRigen Pharmaceuticals, Inc. ' Phase II, 2012 12
aRigen Pharmaceuticals, Inc. ' Phase I, 2012 13
aRigen Pharmaceuticals, Inc. ' Pre-Clinical, 2012 14
aRigen Pharmaceuticals, Inc. ' Discovery, 2012 15
aRigen Pharmaceuticals, Inc. ' Pipeline By Route of Administration, 2012 24



aRigen Pharmaceuticals, Inc. ' Pipeline Products By Mechanism of Action, 2012 25
aRigen Pharmaceuticals, Inc. ' Recent Pipeline Updates, 2012 26
aRigen Pharmaceuticals, Inc. - Dormant Developmental Projects,2012 27
aRigen Pharmaceuticals, Inc., Deals Summary 31
Green Cross Enters Into Licensing Agreement With aRigen 32
Centaur Pharma Enters Into Licensing Agreement With aRigen Pharma 34
aRigen Pharma Enters Into Licensing Agreement With CJ CheilJedang For ARH-1029 35
aRigen Pharma Enters Into Licensing Agreement With Taiho Pharma 36

List of Figures

aRigen Pharmaceuticals, Inc. ' Pipeline by Indication, 2012 7
aRigen Pharmaceuticals, Inc. ' Pipeline by Stage of Development, 2012 9
aRigen Pharmaceuticals, Inc. ' Monotherapy Products in Pipeline, 2012 10
aRigen Pharmaceuticals, Inc. ' Pipeline By Route of Administration, 2012 24
aRigen Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action, 2012 25


Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.


Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 1 500.00 Quantity: _____

Site License--USD 3 000.00 Quantity: _____

Corporate License--USD 4 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________


Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


aRigen Pharmaceuticals, Inc. ' Product Pipeline Review ' 2012

Recomendados

Recomendados

Mais conteúdo relacionado

Destaque

Destaque (9)

Mais de ReportLinker.com

Mais de ReportLinker.com (20)

aRigen Pharmaceuticals, Inc. ' Product Pipeline Review ' 2012